What is the best dose of aspirin in association with P2Y12 antagonists?

被引：3
|
作者：
Cattaneo, Marco [1 ]
机构：
[1] Univ Milan, Osped San Paolo, I-20142 Milan, Italy
来源：
HEART | 2011年 / 97卷 / 03期
关键词：
P2Y(12); RECEPTOR;
D O I：
10.1136/hrt.2010.216812
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：263 / 264
页数：2
相关论文
共 50 条
  • [41] Platelet Inhibition Agents: Current and Future P2Y12 Receptor Antagonists
    Tang, Jie
    Li, Mu-Peng
    Zhou, Hong-Hao
    Chen, Xiao-Ping
    CURRENT VASCULAR PHARMACOLOGY, 2015, 13 (05) : 566 - 577
  • [42] Preclinical and clinical studies with selective reversible direct P2Y12 antagonists
    van Giezen, JJJ
    Humphries, RG
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2005, 31 (02): : 195 - 204
  • [43] Recent Advances in the Development of P2Y12 Receptor Antagonists as Antiplatelet Agents
    Caldwell, Allorie T.
    Watkins, E. Blake
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 49, 2014, 49 : 87 - 99
  • [44] Molecular modeling of purinergic receptor P2Y12 and interaction with its antagonists
    Zhan, Chenyang
    Yang, Jie
    Dong, Xian-Chi
    Wang, Yue-Lan
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2007, 26 (01): : 20 - 31
  • [45] A Critical Appraisal of the Functional Evolution of P2Y12 Antagonists as Antiplatelet Drugs
    Fayaz, S. M. A.
    Rajanikant, G. K.
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (12) : 1625 - 1634
  • [46] IMPACT OF PLATELET TRANSFUSION ON PLATELET ACTIVATION AND AGGREGATION IN CARDIAC SURGERY PATIENTS RECEIVING ASPIRIN AND P2Y12 RECEPTOR ANTAGONISTS
    O'Connor, Stephen A.
    Martin, Rejane
    Amour, Julien
    Abtan, Jeremie
    Kerneis, Mathieu
    Silvain, Johanne
    Leprince, Pascal
    Montalescot, Gilles
    Collet, Jean-Philippe
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E30 - E30
  • [47] Platelet inhibition by P2Y12 antagonists is potentiated by adenosine signalling activators
    Shih, Chih-Chin
    Chan, Melissa, V
    Kirkby, Nicholas S.
    Vojnovic, Ivana
    Mitchell, Jane A.
    Armstrong, Paul C.
    Warner, Timothy D.
    BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (23) : 4758 - 4771
  • [48] Functional testing methods for the antiplatelet effect of P2Y12 receptor antagonists
    Price, Matthew J.
    Barker, Colin M.
    BIOMARKERS IN MEDICINE, 2011, 5 (01) : 43 - 51
  • [49] Inhibition of platelet aggregation by GLS-409, an antagonist of both P2Y1 and P2Y12, is distinct from inhibition by selective P2Y1 and P2Y12 antagonists
    Gremmel, T.
    Yanachkov, I. B.
    Wright, G.
    Michelson, A. D.
    Frelinger, A. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 516 - 516
  • [50] Characteristics of new P2Y12 inhibitors: selection of P2Y12 inhibitors in clinical practice
    Golino, Paolo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 : S22 - S30
12345